Check out our most popular compounded medications! Get Started
Bayview Pharmacy's Hydromorphone HCl 10 mg Slow Release Capsules are formulated with Methocel E4M, a controlled-release polymer. This design allows for the gradual release of the active ingredient over an extended period, providing sustained therapeutic effects. This formulation is used to manage various types of pain including chronic, cancer, neuropathic, postoperative, and arthritis pain. The slow release mechanism also reduces dosing frequency, thereby improving patient compliance.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Bayview Pharmacy is pleased to present our compounded formulation of Hydromorphone HCl 10 mg Slow Release Capsules. This potent opioid analgesic is primarily used for the management of moderate to severe pain. The unique formulation of these capsules incorporates Methocel E4M, a controlled-release polymer. This innovative technology ensures a gradual release of the encapsulated medication, providing a steady and prolonged therapeutic effect.
The slow-release mechanism of Hydromorphone HCl 10 mg Slow Release Capsules allows for a consistent level of pain relief over an extended period, reducing the need for frequent dosing. This makes it particularly beneficial for patients dealing with chronic pain conditions, as it offers sustained relief throughout the day.
However, it is crucial to remember that this formulation should be considered only when other treatments have not provided sufficient relief. Additionally, due to the nature of the active ingredient, this medication should be used with caution in patients with a history of substance abuse or addiction.
If you have any queries or require further information about Hydromorphone HCl 10 mg Slow Release Capsules, please do not hesitate to contact us at Bayview Pharmacy. Our team of experienced compounding pharmacists is always ready to assist you in finding the most suitable treatment option for your specific needs.
Hydromorphone HCl 10 mg Slow Release Capsules are a potent formulation designed to manage moderate to severe pain. These capsules are formulated with Methocel E4M, a type of controlled-release polymer. This innovative technology allows for the gradual release of the encapsulated medication over an extended period, providing sustained therapeutic effects. This slow-release mechanism reduces the need for frequent dosing and promotes improved patient compliance, particularly beneficial for medications requiring a controlled and prolonged release profile.
It is crucial to note that this formulation is not suitable for patients with severe respiratory depression, acute or severe bronchial asthma, or known or suspected paralytic ileus. Regular monitoring for signs of respiratory depression, sedation, and hypotension is recommended for patients taking this medication. Additionally, patients should be advised to abstain from alcohol and other CNS depressants while on this medication.
Patients should also be cautioned against engaging in activities requiring mental alertness, such as operating a motor vehicle or hazardous machinery, until they fully understand how this medication affects them. Regular monitoring for signs of opioid toxicity, including confusion, sedation, and respiratory depression, is also necessary. If any of these signs are present, the dose should be adjusted or discontinued.
Patients should be advised to take this medication exactly as prescribed and not to increase the dose or frequency without consulting their healthcare provider. It is essential to maintain open communication with healthcare providers and to reach out with any questions or concerns regarding this medication.
Hydromorphone HCl 10 mg Slow Release Capsules are a potent, extended-release opioid analgesic designed to manage moderate to severe pain. These capsules are uniquely formulated with Methocel E4M, a type of controlled-release polymer. This innovative formulation allows for the gradual release of the encapsulated medication over an extended period, providing sustained therapeutic effects and a steady level of pain relief.
The slow-release mechanism of these capsules reduces the frequency of dosing, typically to once a day, and improves patient compliance, particularly for those requiring a controlled and prolonged release profile for their medication. The capsules are intended for oral administration and should be swallowed whole with a full glass of water. It is crucial not to crush, chew, or break the capsules as this can interfere with the controlled-release mechanism.
Hydromorphone HCl 10 mg Slow Release Capsules are indicated for a variety of conditions that cause moderate to severe pain, including cancer, post-surgical pain, and chronic pain conditions. It is important to note that this medication is not intended for the treatment of mild pain or pain that can be effectively managed with other, less potent medications.
As with any medication, Hydromorphone HCl 10 mg Slow Release Capsules can cause side effects. These may include nausea, vomiting, constipation, dizziness, drowsiness, and dry mouth. It is essential to discuss any side effects you may experience with your healthcare provider to ensure safe and appropriate use of this medication.
If you have any questions or concerns about Hydromorphone HCl 10 mg Slow Release Capsules, it is recommended to consult with your healthcare provider or pharmacist. They can provide comprehensive information about how this medication works, its potential benefits, and how it can help manage your pain effectively.
Hydromorphone HCl 10 mg Slow Release Capsules is a medication that contains the active ingredient Hydromorphone HCl. It is formulated with Methocel E4M, a type of controlled-release polymer, designed to release the medication gradually over an extended period of time.
Methocel E4M is a controlled-release polymer that allows the medication to be released gradually over an extended period of time. This offers sustained therapeutic effects, reduces dosing frequency, and improves patient compliance for medications requiring a controlled and prolonged release profile.
Slow release formulations offer several benefits. They provide sustained therapeutic effects, reduce the frequency of dosing, and improve patient compliance, especially for medications that require a controlled and prolonged release profile.
The frequency of dosing will depend on your doctor's prescription. However, due to the slow release formulation, the frequency of dosing is typically reduced compared to other formulations.
If you miss a dose, take it as soon as you remember. If it is near the time of the next dose, skip the missed dose. Do not double the dose to catch up. Always follow your doctor's instructions.
No, you should not crush or chew the capsules. Doing so can release all of the drug at once, increasing the risk of side effects. The capsule should be swallowed whole.
Common side effects may include constipation, nausea, vomiting, and dizziness. If any of these effects persist or worsen, tell your doctor or pharmacist promptly.
Before taking this medication, tell your doctor if you are pregnant or breastfeeding. This medication may have undesirable effects on a nursing infant or a fetus.
No, you should not drink alcohol while taking this medication. Alcohol can increase the risk of serious side effects.
If someone has overdosed and has serious symptoms such as passing out or trouble breathing, call emergency services immediately. Symptoms of overdose may include slow breathing, slow heartbeat, coma.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
This preparation is a controlled substance. Additional prescribing, refill, and shipping restrictions apply, and the states Bayview can dispense it to are narrower than for non-controlled preparations.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
